Elsevier

Lung Cancer

Volume 147, September 2020, Pages 187-192
Lung Cancer

Review
Cribriform growth pattern in lung adenocarcinoma: More aggressive and poorer prognosis than acinar growth pattern

https://doi.org/10.1016/j.lungcan.2020.07.021Get rights and content
Under a Creative Commons license
open access

Highlights

  • Cribriform growth pattern is more aggressive than acinar growth pattern in lung adenocarcinoma.

  • Cribriform component present were associated with increased risk of recurrence and death compared with acinar pattern.

  • Cribriform component was associated with fusion gene mutations (ALK, ROS1, and RET).

Abstract

The predictive value of prognosis based on the histopathological subtype is a critical criterion in the new classification of lung adenocarcinoma published in 2011 by the International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS) (IASLC/ATS/ERS). In this new classification, the differences of histopathology and prognosis are two considerable parameters to classify the subtypes of lung adenocarcinoma. Cribriform growth pattern is regarded as a variant of acinar growth pattern in lung adenocarcinoma, however, more and more studies pointed out that cribriform growth pattern is associated with more aggressive histopathological structures, higher proportion of recurrence rates, and shorter postoperative survival than acinar growth pattern. These features are similar to solid or micropapillary predominant adenocarcinoma. In this review, we summarized the clinicopathological features, prognosis, and genetic variations of cribriform growth pattern of lung adenocarcinoma, and provided a novel insight into the diagnosis and treatment of cribriform lung adenocarcinoma.

Keywords

Cribriform lung adenocarcinoma
Clinicopathological features
Prognosis
Genetic variations

Abbreviations

AAH
atypical adenomatous hyperplasia
AIS
adenocarcinoma in situ
MIA
minimal invasive adenocarcinoma
IA
invasive adenocarcinoma
LPA
lepidic predominant adenocarcinoma
APA
acinar predominant adenocarcinoma
PPA
papillary predominant adenocarcinoma
SPA
solid predominant adenocarcinoma
MPA
micropapillary predominant adenocarcinoma
CPA
cribriform predominant adenocarcinoma
HPF
High-Power Field
STAS
tumor spread through air spaces
OR
odds ratio
RFP
recurrence-free probability
HR
hazard ratio
RFS
recurrence-free survival
OS
overall survival
DFS
disease-free survival
PRS
post-recurrence survival
KRAS
kirsten rat sarcoma viral oncogene
ALK
anaplastic lymphoma kinase
ROS1
ROS proto-oncogene 1, receptor tyrosine kinase
RET
ret proto-oncogene
EGFR
epidermal growth factor receptor
CIR
cumulative incidence recurrence

Cited by (0)